%0 Journal Article
%T Celebrating a breakthrough: FDA endorses encorafenib plus binimetinib alongside two companion diagnostics for BRAV600E mutant metastatic non-small cell lung cancer.
%A Abbasi HQ
%A Oduoye MO
%A Goyal A
%J Int J Surg
%V 110
%N 4
%D 2024 Apr 1
%M 38668653
%F 13.4
%R 10.1097/JS9.0000000000001044